Trump Calls for Totally Independent New Fed Chair Amid Pressure on Predecessor CMS Energy Analyst Coverage and Market Sentiment Shells Capital Return Strategy Draws Renewed Investor Attention Powell Vows No Shadow Chair Role as Historic Fed Overlap Looms with Warsh Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Push Oil to New Highs This Summer Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline Hurco Companies Inc HURC Q1 2026 Earnings Loss Reported Amid Challenging Demand Stock Edges Higher IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance Destination XL Group Q1 2026 Earnings Deep EPS Miss Sends Stock Lower Legacy Education Inc LGCY Q1 2026 Earnings Strong EPS Beat Despite Revenue Headwinds and Stock Pullback Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported JewettCameron Trading JCTC Rallies 56 Approaches Key Resistance at 236 Erayak Power Solution Group Inc RAYA Rises 16 as Stock Holds Above Key Support SmartKem Inc SMTK Edges Higher MicroCap Stock Holds Above Key Support After Modest Gain IceCure Medical ICCM Nears Key Support as Selling Pressure Moderates Sunrise Realty Trust SUNS Gains 134 as Stock Approaches Key Resistance Level GPI Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick WHR Q1 2026 Earnings Deep EPS Miss Sends Shares Lower MMM Q1 2026 Earnings Earnings Beat Estimates on Cost Discipline and Operational Efficiency CRGY Q1 2026 Earnings EPS Surges Past Estimates Delivering 52 Surprise Antero Midstream Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Oxford Lane Capital Corp OXLCG Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short Trump Asks Supreme Court to Delay TikTok Ban Citing National Security and Free Speech Concerns HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback